Podcasts about Dross

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, guest host Erin Schenk, MD, PhD, at the University of Colorado Anschutz in Aurora, an associate professor of medicine in the Division of Medical Oncology, sat down with D. Ross Camidge, MD, PhD, to highlight Dr Camidge's storied career and life. Driven by a relentless curiosity that often manifested in him "interrogating" those around him, Camidge chose a career in medicine because of the immediate effect he saw it could have on people's lives.His path included a formative gap year working at McDonald's and serving as a caregiver for a man with cerebral palsy. After studying at Oxford, he faced a significant professional and personal low when pursuing his PhD at Cambridge. Struggling with a difficult project, he persevered by pivoting his research and finding resilience through peers, eventually returning to practicing clinical medicine and finding his calling in oncology due to its unique overlap of molecular biology and opportunities for deep patient connection.Seeking further opportunities, Dr Camidge moved to the United States to lead the lung cancer program at the University of Colorado School of Medicine. He became a pivotal figure in the development of targeted therapies, specifically crizotinib for ALK-positive lung cancer. Beyond drug development, he championed the use of molecular profiling and established a global remote second opinion program.In 2022, Dr Camidge's perspective shifted profoundly following his own lung cancer diagnosis. This experience forced him to evolve from a "questioning machine" into someone more amenable to accepting love and support. He now integrates this dual perspective into his work, emphasizing that oncology must go beyond science to address the human experience of treating real people.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Karen L. Reckamp, MD, director of Medical Oncology, associate director of Clinical Research, and the medical oncology director of the Lung Institute at Cedars Sinai in Los Angeles, California.Drs Camidge and Reckamp discussed Dr Reckamp's journey as an oncology specialist and now a caregiver for her husband, who has cancer. Reckamp's career was inspired by her family's history with BRCA-related cancers. She pursued an academic path that eventually led her to Los Angeles, where she became a leader in thoracic oncology during an era of genomic breakthroughs.In late 2024, her husband, a fellow oncologist, was diagnosed with pancreatic cancer shortly after a clear annual scan. Reckamp described the jarring transition of receiving the diagnosis and the ensuing emotions balanced with medical pragmatism. Bob underwent intensive treatments that have affected his physical health and daily life.Reckamp offered a candid look at the dual role of a physician-caregiver. She continues to work, however, her husband's cancer diagnosis has changed her practice. Now, she is more sensitive to chemotherapy toxicities in her patients that she might have previously minimized. She also highlighted the invisible load of caregivers who must manage their own emotions and remain available for patient needs.Ultimately, Reckamp emphasized the necessity of a support network, crediting their long-time nanny and overall community with maintaining her family's stability. By allowing different people to hold different pieces of the emotional burden, Reckamp shared that her family is finding a way to move forward amidst the uncertainty of this cancer diagnosis.

According to Proverbs 25:4 “Take away the dross from the silver, and the smith has material for a vessel”. According to Proverbs 17:3 “The crucible is for silver, and the furnace is for gold, and the LORD tests hearts.”  Taking these references together we can extend and apply the analogy of precious metal refining to the sanctification process of our hearts and lives. Analyzing Proverbs 17 with this illustration in mind, Solomon reveals categories of dross that godly wisdom teaches us to recognize and remove

Prov. 25:4-5 expounds & applies the analogy of pure metals vs. dross. Another example in Proverbs utilizing similar picture language to Prov. 17:3. When the heart is tested by the refining fires of life, the process is designed to remove some elements and refine others.  When the heat is turned up, the difference between precious metals and dross or impurities becomes increasingly apparent.  The book of Proverbs serves as a literary version of this process.  Solomon turns up the heat of truth and when his words are taken to heart, the contrast between folly and righteousness is magnified.

Fire is not an enemy of the gold; it is its greatest friend. The heat of the furnace isn't designed to destroy the metal, but to reveal its true essence and consume the dross that doesn't belong. The same is true of our faith. When we find ourselves in the heat of a trial, God isn't looking to burn us—He is looking to burn away the insecurities, the pride, and the distractions that hinder our growth. The fire doesn't take away who you are; it reveals who you were always meant to be.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Charles D. Blanke, MD, FACP, FASCO, a professor of medicine in the School of Medicine at the Oregon Health & Science University (OHSU) Knight Cancer Institute in Portland.Drs Camidge and Blanke discuss Dr Blanke's unique career path from pioneering targeted cancer therapies to becoming a leading advocate for medical aid in dying. A Type 1 diabetes diagnosis directed Dr Blanke toward an interest in internal medicine and oncology. During his fellowship and early faculty days, he established a reputation for his hard work pursuing research opportunities, even when initial projects were unsuccessful.Blanke's most transformative scientific achievement occurred at OHSU, where he spearheaded the use of Imatinib (Gleevec) for the management of gastrointestinal stromal tumor (GIST). By targeting the KIT mutation, this research turned a previously untreatable malignancy into one with a high response rate, marking a landmark moment for personalized oncology.Equally significant in Dr Blanke's career is his role in medical aid in dying. Practicing in Oregon, the first state to legalize the option, he has written hundreds of prescriptions for patients with terminal diseases. Blanke views medical aid in dying as a vital extension of patient care.As the former chair of SWOG, Dr Blanke modernized clinical research by introducing term limits, increasing access to clinical trials among, and championing the development of pragmatic trials with broader patient eligibility criteria. Throughout his tenure, he emphasized the importance of patient advocacy and the altruistic nature of cooperative research. Having recently stepped down from his leadership at SWOG, he intends to focus his future efforts on patient rights and medical aid in dying advocacy.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Robert A Meguid, MD, MPH, FACS, a thoracic and cardiac surgeon, as well as a professor of cardiothoracic surgery, at the University of Colorado in Aurora.Drs Camidge and Meguid discussed Dr Meguid's journey into medicine, which was heavily influenced by his parents, both of whom were academic physicians. A first-generation American, Dr Meguid grew up watching his father operate and working in his father's research lab, experiences that ignited a lifelong interest in the scientific method and patient care. Dr Meguid pursued a combined 8-year medical program before matching into a residency in general surgery. During his residency, he spent 3 years in research, earning a master's degree in public health and shifting his focus toward surgical outcomes and risk analysis. After completing a cardiothoracic fellowship, he joined the University of Colorado, where he helped expand the thoracic surgery program and pioneered robotic-assisted techniques.A shift in Dr Meguid's perspective occurred when he suffered a life-threatening medical event during a family vacation in Australia. He contracted fulminant septic shock resulting from human metapneumovirus and group A strep, leading to respiratory and renal failure. After being intubated for several weeks and losing significant muscle mass, he was life-flighted back to his own ICU in Denver to begin recovery. This experience as a patient, during which he had to relearn how to stand and move, deepened his empathy and reinforced his commitment to patient-centered care.Currently, Dr Meguid is a leader in his field, focusing on thoracic oncology and complex chest wall reconstructions, such as that of the adult pectus excavatum. He remains dedicated to academic research on surgical risk assessment, ensuring that patients are empowered to make informed decisions about their care.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Camidge sat down with Dajan O'Donnell, PhD, who is the director of Research Partnerships at Cancer Research Society in Montreal, Canada.Camidge and O'Donnell discussed O'Donnell's journey into science. After being steered away from a career in science during grade school but re-igniting his interest in the field as a young adult, O'Donnell earned a PhD in neurology and neurosurgery and then worked for AstraZeneca, where he helped build a Montreal-based research unit from scratch that specialized in identifying novel targets for chronic pain. O'Donnell's transition to the nonprofit sector was sparked by the closure of AstraZeneca's Montreal site and a personal diagnosis of a desmoid tumor that required multiple aggressive surgeries, an experience that fueled his passion for supporting research that directly affects patients. Before joining Cancer Research Society, O'Donnell worked for Exactis Innovation, where he navigated complex provincial health care barriers to create a national molecular registry for patients with cancer.Since joining Cancer Research Society, O'Donnell has expanded the organization's reach. Despite its relatively small size, Cancer Research Society is highly efficient, focusing almost entirely on funding research across all cancer types. Under O'Donnell's leadership, the organization's financial commitment to cancer research has increased. Currently, O'Donnell is spearheading an unprecedented initiative to support investigator-initiated clinical trials in Canada. By leveraging partnerships with other agencies and foundations, this project aims to enhance clinical trial capacity across the country. This initiative serves as a cornerstone of O'Donnell's legacy as he prepares to transition into an advisory role over the next few years.

Welcome to Day 2838 of Wisdom-Trek. Thank you for joining me. This is Guthrie Chamberlain, Your Guide to Wisdom. Day 2838 – Wisdom Nuggets – Psalm 119:113-120 – Daily Wisdom Wisdom-Trek Podcast Script - Day 2838 Welcome to Wisdom-Trek with Gramps! I am Guthrie Chamberlain, and we are on Day 2838 of our Trek. The Purpose of Wisdom-Trek is to create a legacy of wisdom, to seek out discernment and insights, and to boldly grow where few have chosen to grow before. The Title for Today's Wisdom-Trek is: The Samekh of Support – An Undivided Loyalty In our previous episode on this grand expedition, we navigated the dark and treacherous trails of the fourteenth stanza in Psalm One Hundred Nineteen, the “Nun” section. We learned that to survive the suffocating darkness of a hostile world, we must carry the lamp of God's Word. We discovered that the Creator does not typically give us a massive searchlight to illuminate the next twenty years, but rather, a small, flickering clay lamp that provides just enough truth for the very next step. We promised to keep walking, carefully avoiding the tripwires of the wicked, and we claimed the eternal testimonies of the Lord as our greatest, permanent heritage. Today, we take our next courageous step forward, transitioning from the imagery of a lamp, to the reality of a fortress. We are entering the fifteenth stanza of this magnificent, alphabetical mountain. We are exploring the “Samekh” section, covering Psalm One Hundred Nineteen, verses one hundred thirteen through one hundred twenty, in the New Living Translation. In the ancient Hebrew alphabet, the letter “Samekh” was originally depicted as a prop, a pillar, or a sturdy shield. It represents something that you can lean your entire weight against when you are utterly exhausted, knowing that it will not collapse. This imagery forms the absolute backbone of this entire stanza. The psalmist is tired of the spiritual compromise around him. He is drawing a hard line in the sand, rejecting the cultural pressure to mix his faith with the idolatry of the world. He is declaring an undivided loyalty to Yahweh, and in return, he is asking the Creator to prop him up, and shield him from the fallout. Let us step onto the trail, and learn how to lean on the pillar of truth. The first segment is: The Hatred of the Divided Heart and the Divine Shield Psalm One Hundred Nineteen: verses one hundred thirteen through one hundred fifteen. I hate those with divided loyalties, but I love your instructions. You are my refuge and my shield; your word is my source of hope. Get out of my life, you evil-minded people, for I intend to obey the commands of my God. The stanza opens with a jarring, absolute declaration: “I hate those with divided loyalties.” Other translations render this as, “I hate the double-minded.” To modern ears, this sounds harsh, perhaps even unloving. But to understand this, we must look through the lens of the Ancient Israelite worldview. In the ancient Near East, the greatest threat to Israel was not atheism; it was syncretism. Syncretism is the blending of different religions. The surrounding pagan nations, governed by the rebel gods of the Divine Council, constantly pressured the Israelites to compromise. The temptation was to worship Yahweh on the Sabbath, but then sacrifice to Baal on Tuesday to ensure a good harvest, or pray to Asherah for fertility. A person with "divided loyalties" is someone who limps between two opinions. They want the blessings of the Creator, but they also want to participate in the corrupt, chaotic systems of the rebel principalities. The psalmist hates this double-mindedness, because it is spiritual treason. It is a fundamental betrayal of the cosmic order. You cannot serve two masters. In stark contrast, he declares, “...but I love your instructions.” He refuses to mix his devotion. He wants the pure, unadulterated blueprint of the Most High God. Because he refuses to compromise, he immediately makes himself a target. The culture does not tolerate exclusive loyalty to Yahweh. So, he runs to his defense: “You are my refuge and my shield; your word is my source of hope.” Here is the “Samekh” in action. A refuge is a place to hide, and a shield is a mobile defense that deflects incoming arrows. The psalmist realizes that his own human willpower is not a sufficient defense against the spiritual warfare of his culture. If he is going to stand firm against the pressure of double-mindedness, he must hide his mind behind the massive, impenetrable shield of the Creator. This fierce loyalty leads to a drastic, practical boundary. “Get out of my life, you evil-minded people, for I intend to obey the commands of my God.” Literally, the Hebrew says, “Depart from me, you evildoers.” The psalmist recognizes that bad company corrupts good character. The “evil-minded people” are those who have fully embraced the chaotic rebellion of the world. They are the agents of compromise. The psalmist is not just being antisocial; he is executing a spiritual quarantine. He knows that if he allows these voices of compromise to constantly whisper in his ear, his own heart might become divided. He draws a firm, unyielding boundary, protecting his environment so that he can fulfill his singular intention: obeying the commands of his God. The second segment is: The Plea to be Propped Up Psalm One Hundred Nineteen: verses one hundred sixteen and one hundred seventeen. Lord, sustain me as you promised, that I may live! Do not let my hope be crushed. Sustain me, and I will be rescued; then I will meditate continually on your decrees. After boldly drawing his boundaries and evicting the evildoers, the adrenaline fades, and the psalmist feels his own profound human weakness. He cries out, “Lord, sustain me as you promised, that I may live!” The Hebrew word used here for “sustain” is samakh, which is the exact verbal root of the letter “Samekh.” It literally means to lean your hand heavily upon something, to prop up, to uphold, or to brace. Think of a timber pillar holding up the collapsing roof of a mine shaft. The psalmist feels the crushing, gravitational weight of the world pressing down on his shoulders. He has chosen the hard path of undivided loyalty, and the pressure is threatening to cave his chest in. He begs Yahweh, “Step under this weight with me. Be my pillar. Prop me up, because if You do not uphold me, I am going to collapse, and my life will be extinguished.” He anchors this desperate plea to the covenant, asking God to intervene “as you promised.” He adds a poignant, emotional request: “Do not let my hope be crushed.” Or, “Do not let me be ashamed of my hope.” He has bet everything on the invisible reality of the Creator's kingdom. He has alienated the powerful, evil-minded people of his community to stay true to the Torah. If God fails to support him, his entire worldview will shatter, and the mockers will have won. He repeats the plea for emphasis: “Sustain me, and I will be rescued; then I will meditate continually on your decrees.” Notice the cause and effect. He does not say, “I will meditate, and therefore I will rescue myself.” He acknowledges that salvation comes entirely from the external, upholding power of God. The rescue must happen first. When Yahweh steps in and braces the collapsing walls of his life, it frees the psalmist's mind. Once he is secure, leaning safely against the pillar of grace, he can return to his favorite occupation: meditating continually on the eternal decrees of the King. The Third segment is: The Dross of the Earth and the Purity of Justice Psalm One Hundred Nineteen: verses one hundred eighteen and one hundred nineteen But you have rejected all who wander from your decrees. They are only fooling themselves. You skim off the wicked of the earth like scum; no wonder I love to obey your laws! From the safety of his divine refuge, the psalmist looks out at the fate of the double-minded. He makes a sobering, objective observation about cosmic justice: “But you have rejected all who wander from your decrees. They are only fooling themselves.” The rebel gods promise freedom and power to those who wander off the path, but the psalmist reveals the ultimate, tragic reality: wandering leads to rejection. The Most High God will not permit the universe to remain in a state of chaotic rebellion forever. The people who think they are outsmarting the system, playing both sides with divided loyalties, are entirely deceived. The literal translation is, “their deceit is falsehood.” They are living in an illusion, a house of cards that is destined to fall. The psalmist then uses a startling, industrial metaphor to describe God's judgment: “You skim off the wicked of the earth like scum.” The Hebrew word here is sig, which refers to dross, or slag. In the ancient metallurgical process of refining silver or gold, the raw ore was placed in a...

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Alex Alvarez, a board-certified civil trial lawyer who specializes in tobacco litigation and jury selection. Camidge and Alvarez discussed Alvarez's career path, which he attributes to a deep-seated passion for upholding justice. Alvarez's professional life began early, when he became one of the youngest police officers in Miami. After working in patrol during a period of significant civil unrest, he moved into the detective bureau, eventually joining the homicide division. There, he worked on high-profile investigations. During a federal trial for corrupt officers, Alvarez served as the lead investigator and sat at the counsel table, an experience that inspired him to become a trial lawyer.Although Alvarez initially planned to be a prosecutor, a prominent trial lawyer convinced him to enter private practice, focusing on high-end products liability and medical negligence. Alvarez eventually founded his own firm and became a leading figure in tobacco litigation. His cases focus on corporate malfeasance, arguing that tobacco companies engineered cigarettes to be addictive. He also sues for fraud, citing the industry's history of denying the health risks associated with cigarettes and the marketing flaws surrounding "safer" cigrette alternatives. A master of jury selection, Alvarez has tried several tobacco cases. He emphasized the importance of finding jurisdictions where jurors are less likely to blame the smoker and more likely to hold corporations accountable.Alvarez's law firm is a family-run business involving his children and relatives. Today, Alvarez is shifting toward consulting and mentoring the next generation of lawyers to continue the fight against tobacco.

Merriam-Webster's Word of the Day for March 27, 2026 is: dross • DRAHSS • noun Something referred to as "dross" is of low value or quality. Dross may also be used as a technical term to refer to unwanted material that is removed from a mineral to make it better. // He's a skilled editor who has a talent for turning literary dross into gold. See the entry > Examples: "Hollywood optimists argue that AI's greatest weakness will be originality. After all, viewers already complain of being deluged with formulaic, low-budget dross churned out by streaming platforms because an algorithm deems it popular." — Tom Leonard, The Scottish Daily Mail, 23 Feb. 2026 Did you know? Dross has been a part of the English language since Anglo-Saxon times. It comes from the Old English word drōs, meaning "dregs," those solid materials that fall to the bottom of a container full of a liquid such as coffee or wine. While dross today is used to refer to anything of low value or quality, its earliest use is technical: dross is a metallurgy term referring to solid scum that forms on the surface of a metal when it is molten or melting—remove the dross to improve the metal. The metallurgical sense of the word is often hinted at in its general use, with dross set in contrast to gold, as when 19th century British poet Christina Rossetti wrote "Besides, those days were golden days, / Whilst these are days of dross."

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Khari Reed, MHSA, FACHE. Dr Reed is the vice president of Oncology Services at HonorHealth in Scottsdale, Arizona.Drs Reed and Camidge dug into what sparked Dr Reed's illustrious health care career. Dr Reed's journey began on the south side of Chicago, where he was raised in the neighborhood of Chatham. Influenced by his parents' investment in community building, he grew up with a commitment to education and giving back to those around him. Dr Reed pointed out how his affinity for health care came from his early time spent in the hospital due to childhood asthma, which caused him to develop an appreciation for the physicians and health care workers that helped him feel better.Dr Reed's career journey is exemplary of a commitment to clinical excellence, operational resilience, and diverse experiences. From his beginnings at the University of Michigan in Ann Arbor to a years-long career wearing many hats for The John Hopkins Hospital in Baltimore, Maryland, to now leading cancer care at Honor Health, Dr Reed has earned his stripes as a decorated and versatile health care professional.Overcoming unfavorably stacked odds has been a common theme woven throughout every stop of Dr Reed's career. At the Loyola University Medical Center in Chicago, Illinois, Dr Reed led the oncology service line through the COVID-19 pandemic, establishing an incident command center that kept ambulatory cancer care operational when other departments closed. Moreover, Dr Reed navigated institutional barriers by completing a rigorous self-designed career plan, mastering complex financial systems, volunteering to gain practical experience, and breaking racial stigmas in health care. Now at HonorHealth, Dr Reed continues to treat patients like family and eyes future career advancements at the hospital, focused on creating self-sustaining organizations that prioritize high-quality oncology care.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Tim Clackson, PhD. Dr Clackson is a biotechnology executive at Kesmalea Therapeutics.Drs Camidge and Clackson discussed Dr Clackson's career journey through the biotechnology field, which began when his innate curiosity about biology and evolution led him to study biochemistry. He then pursued his PhD and was part of the small team that developed antibody phage display libraries, a breakthrough technology that allows scientists to mimic the immune system in a test tube to find specific antibodies. This work was foundational to the discovery of major drugs and contributed to the awarding of a Nobel Prize in 2018.In 1991, Dr Clackson moved to the US to pursue a postdoc at Genentec, where he was inspired by the company's vibrant and optimistic research environment. He then joined Ariad Pharmaceuticals, where he stayed for more than 20 years, evolving from a bench scientist to president of R&D. A major highlight of his tenure was the development of ponatinib (Iclusig) for the treatment of patients with chronic myeloid leukemia. He also navigated significant challenges, including ponatinib's temporary market withdrawal due to safety concerns, which the company eventually resolved by narrowing the drug's clinical application.In the following years, Dr Clackson transitioned into chief executive officer roles at other biotech firms, such as IDRx. He noted that although acquisitions often result in leadership changes—humorously stating, "the higher you are, the quicker you go"—he enjoyed the storytelling aspect of pitching scientific strategies to investors. In the present day, Dr Clackson remains active in the biotechnology industry through board service and entrepreneurship.

Hello you beautiful people!We begin the episode with a Jack Ask question from listener Kevin Church, apologies because it's Valentine's Day related not Christmas.Do you know what the word 'Dross' means? Well, although I use it frequently, I didn't, but Bob Baker explains it all in Do You Hear What I Hear.This episode's version of A Christmas Carol is called Estrella Scrooge: A Christmas Carol with a Twist. It was made during Covid and every actor was filmed separately. It's not great, but it's not awful either.Then Bob Baker is back with Where are you Christmas? and this time he's looking at Melbourne in Australia.Check out Bob's podcast here:  https://4fpodcast.buzzsprout.comNext up my best friend (self-appointed), Chris Cavanagh, tells us his story about how he found out the truth about Santa Claus.Then it's The Christmas Quiz and I scored 7. Last episode loads of people beat me, let's hope that doesn't happen again.The recommendation is The Tim Vine Chat Show. It was a show on BBC Radio 4 and it's just delightful. Hopefully this link will work in your country:www.bbc.co.uk/programmes/b08770wq/episodes/playerGet in touch:Email: totalchristmas@gmail.comWeb: totalchristmaspodcast.comMerry Christmas!

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Robert Kantor, MD. Dr Kantor is associate medical director of Medical Oncology & Hematology at Private Health Management.Drs Camidge and Kantor reflected on Dr Kantor's decades-long career. Inspired by his father's devotion to patients, Dr Kantor fast-tracked his education, entering medical school at Wayne State University without completing an undergraduate degree. Following fellowship, he intentionally chose private practice over academic oncology to focus on direct patient care and making a difference in the lives of patients' families.Dr Kantor's career illustrates the shifting landscape of American medicine. He has navigated various oncology practice models, including a corporate merger that he felt compromised patient care. In 2008, he took the risk of launching his own solo practice, successfully bringing trusted staff and a dedicated patient base with him.Dr Kantor eventually retired from clinical practice due to burnout, which was exacerbated by corporate management challenges and the inefficiencies of electronic medical records. His retirement evolved into an "encore career" as an associate medical director for Private Health Management. In this consultative role, he provides clinical oversight for complex oncology cases, helping patients navigate toward personalized cancer vaccines, clinical trials, and cutting-edge therapies. Dr Kantor expressed that this work has brought him renewed enthusiasm for the field of oncology, as it allows him to use his decades of experience with a basis of a better work-life balance. He remains passionate about how these high-end, personalized technologies will eventually make their way into routine clinical practice to benefit the broader patient population.

Este video fue producido y escrito antes de que Dross lanzará la segunda parte el monstruo roto la versión de la psiquiatra.esta ocasión hablamos de uno de los casos que más han llamado la atención en los últimos días empezamos el año con una de las historias más fuertes y perturbadoras de todo este 2026 la historia es sobre Dross y su sección querido Dross la historia habla de una mujer que recibió maltrato por parte de psiquiatras y doctores esto es proyecto inframundo Y recuerda... no confíes en nadie.

En la novena edición de Código Nocturno, te contamos y discutimos las noticias más populares de la primera semana de Febrero del 2026. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Music and arts for change initiatives, such as Music & Arts For Change in Florida and the Playing For Change Foundation, leverage creative expression to foster community development, fund education, and drive social transformation. These programs, often supported by grants like those from The Music Man Foundation, promote healing, mental wellness, and youth engagement, with over $4 million recently awarded to initiatives enhancing schools and community health. Key Aspects of Music and Arts for Change:Educational Impact: Programs provide essential arts education, filling gaps where schools lack music, visual arts, dance, and theater programs.Community and Social Action: Art and music are used as tools to unite, amplify voices, and support social movements. Initiatives often focus on providing free resources to underserved communities.Funding and Advocacy: Organizations like The Music Man Foundation and @artforchangemiami fund, support, and advocate for policies that integrate arts into schools and healthcare.Global Reach: Groups like the Playing For Change Foundation connect local efforts to international projects, aiming to create lasting, positive change through music. These initiatives range from local community fundraisers providing for school needs to international projects like the Arts for Social Change Jam. Support the show

Engel, Atro, Vega y Coreallan sin filtro en un episodio donde se ponen sobre la mesa temas incómodos, polémica en redes y cultura pop bajo la lupa. 🦠 Sarampión en México: qué está pasando y por qué debería importarte 🎬 Daredevil: Born Again T2: el tráiler analizado sin hype gratuito 📱 Dross, el “Monstruo Roto” y la irresponsabilidad de los influencers: opinión directa y debate necesario Análisis frontal, cotorreo intenso y cero complacencia. Si te gusta el contenido directo y sin maquillaje, este episodio es para ti. 🎧 Escúchalo ahora y únete a la conversación. #podcast #inmamables #mexico #LosInmamables #Episodio346 #Daredevil

Emisión: 28/01/2026 Temporada 17 Episodio 01 Abstract: ¿Estamos viviendo los últimos minutos de la diplomacia global? analizamos por qué el Doomsday Clock se ha situado a solo 85 segundos de la medianoche. Exploramos la crisis interna en EE. UU. tras los incidentes del ICE en Minneapolis y cómo la administración Trump está utilizando la migración como un arma política. Además, desmenuzamos la situación de México Acorralado: entre la revisión del T-MEC, la guerra comercial contra China, la supervivencia o una entrega de soberanía, el colapso energético en Cuba y mucho chismecito más. Mónica Maciel y Salvador Gaviño Romero los acompañan con todo el sazón en la mesa número 1 de El Ajo, Estamos en todos los moles. Conviértete en miembro de este canal para disfrutar de ventajas: https://www.youtube.com/channel/UCovCkTauWfbvVYKbYjAYw1w/join Gracias por Suscribirte: https://www.youtube.com/user/recetarioelajo?sub_confirmation=1 Follow en Twitter: https://x.com/recetarioelajo Like en FB:https://www.facebook.com/recetarioelajo/ WEB: http://www.elajoproducciones.com Podcast Ivoox: https://go.ivoox.com/sq/2458 Ajófono:(+52) 56.100.56.1.56 (MX) Ajomail: elajo.producciones@gmail.com #ElAjo Animación Intro: cortesía de El Último Escriba Animación Logos: cortesía de El Último Escriba Música de Fondo: cortesía de Roberto Connolly ***** Enlaces de Interés ***** Anacrónico ¡Ya Disponible! : https://a.co/d/8Z5OABJ PODCAST Dante: https://www.youtube.com/watch?v=rZkE2IKIJVc Dante Vanzetti spotify: https://open.spotify.com/artist/08MlOZSrQ6psjZbZWEVCgH?si=j6fSsfBATw-HwwjInMyOCg Dante Vanzetti YT: https://youtu.be/N8BJxFrRbGQ?si=ACbIH2GEOQoVzbkK Yasfer Cuadrante Mágico: https://yasferlvx.wixsite.com/arcano-obscuro-radio Marcos Urbex: https://youtube.com/@markoz320?si=qH2JyDW1gX2ohDH_ Mónica Canal Misterio: https://youtube.com/@proyectoguionenblancomiste3209?si=xt2T2iYtlIlwag-f Canal Vladimir Chargoy: https://www.youtube.com/@vladimirchargoy1711 TEMAS: 0:00:00 Antesala 0:06:00 Inicio 0:10:00 Dross vs SrDr 0:42:00 Chat 0:52:00 Trump, Interocéanico, Almilcar 1:30:00 Trump Tres Bandas, Europa, EUA, Latam 2:00:00 Tener Todo el Poder 2:35:00 Fanatismo 3:06:00 Saludos

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Justin Call, MD. Dr Call is a medical oncologist and hematologist at Utah Cancer Specialists in South Jordan.Dr Call explained that he has taken a unique professional path, transitioning from practicing as a general community oncologist to becoming a full-time phase 1 principal investigator within a community practice setting. He explained that he grew up in Salt Lake City, Utah in a family of educators and accountants, though he was heavily influenced by several uncles who were physicians, including one oncologist. After completing his medical training at the University of Colorado, he chose community oncology over academia because he wanted to remain a generalist who could treat all tumor types rather than being restricted to a specific disease group. A formative rotation at Rocky Mountain Cancer Centers solidified this desire, as Dr Call noted he was impressed by the deep knowledge required to treat various cancers and the positive atmosphere of outpatient care.Dr Call emphasized that his personal life significantly influenced his career choices. His son, Trevor, was diagnosed with autism at 18 months old. This diagnosis eventually led the family to move from a rural practice in Petoskey, Michigan, back to Utah to access better support services and be closer to family. His son's experience also inspired Call's wife to earn a master's degree in special education.Upon returning to Utah Cancer Specialists, Dr Call initially participated in phase 3 trials. However, he retained an interest in early-phase research from his fellowship days. In 2016, he began building a boutique phase 1 program, initially starting with just 2 hours of dedicated time per week. In 2020, his practice partnered with START (South Texas Accelerated Research Therapeutics) to launch a dedicated, full-time, community-based phase 1 program. Dr Call noted that this model is rare because phase 1 trials are highly competitive and require specialized infrastructure, such as dedicated pharmacists, coordinators, and equipment for processing pharmacokinetic samples.

Championship Game: Mikey vs MuesMues looking for his first ever title, Mikey looking to be the 2nd person ever in league history to go back to back. 3rd place game: Fraz vs D-Ross

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Tom Fleming, PhD, a professor of biostatistics at the University of Washington School of Public Health in Seattle. Drs Camidge and Fleming discussed how Fleming's interest in biostatistics led to a multifaceted career in clinical trial design and analysis. Fleming pursued a PhD in math and statistics and spent his early career learning to bridge quantitative sciences with clinical medicine, working on landmark trials for adjuvant colon cancer and debunking megadoses of Vitamin C as a cancer treatment. A primary focus of Fleming's career was pioneering the use of Data Monitoring Committees (DMCs) in oncology research to safeguard patient interests and trial integrity, later convincing organizations like SWOG to adopt DMCs to prevent premature data releases and biases. He also co-developed the O'Brien-Fleming monitoring boundary, a statistical framework that allows trials to stop early for efficacy only when the signal is undeniably compelling, thereby protecting scientific rigor. After moving to the University of Washington, Fleming expanded his focus into infectious diseases. He led international efforts that revolutionized HIV/AIDS prevention, including demonstrating a reduction in heterosexual transmission of the disease through antiretrovirals and significantly reducing mother-to-child transmission in resource-limited settings. Fleming remains a staunch advocate for confirmatory trials and the use of overall survival as the "gold standard" end point, often expressing skepticism toward surrogate biomarkers like progression-free survival. In the episode, he emphasized that rigorous science is possible even in the most challenging environments, provided there is a commitment to clinical equipoise and high patient retention. Outside of his professional life, Fleming prioritizes family and coaches youth soccer teams, reflecting his belief in the power of collaboration.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Keith Singer, the founder and executive director of Catch It In Time. Camidge and Singer discussed how Singer's background in broadcasting and cable television has led to a career in promoting cancer awareness. Although Singer initially wanted to be an astronaut, a decline in aerospace engineering jobs during the 1970s and a love for the technical side of high school theater led Singer toward television. He left college early and started his career in Cincinnati, first running a boom microphone and later directing newscasts. Singer explained the career hurdles he faced, noting that they led to opportunities for him to hone his skills and exercise creative freedom. In the mid-1980s, a project involving a new pacemaker sparked Singer's interest in using video for health care education. This fascination led him to co-create an innovative platform that broadcast medical programming for physician continuing medical education. Driven by seeing friends and family struggle with cancer, Singer founded the nonprofit Catch It In Time in 2011. His key communication strategy is that cancer should be the supporting actor, not the lead, allowing stories to appeal to targeted audiences based on their hobbies or professions, with cancer awareness as the secondary message. Catch It In Time is currently developing The User's Guide to Oncology, a software-based program that uses gaming technology to guide patients with lung cancer, providing essential information to help them have better conversations with their care teams. Singer stressed the importance of short video content for garnering views for this type of content. Notably, Catch It In Time recently produced a song titled "Breathe Again" by Lilliana De Los Reyes. "Breathe Again" can be found on all major streaming platforms, and all proceeds are dedicated to cancer awareness and research.

Derek D. Ross returns as we continue our conversation on Black men + mental health as we unpack how he:- Learned how to place himself on the schedule- Thriving in transition- Being seen without explanation- Moving with clarity vs. an emotional response...and so much more!Support the showFB @thespeakherpodcast | IG @camille.essick | camilleessick.com YT: CamilleEssick "Where Innovators & Creators Connect".**I do not own the rights to this music.**

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Gideon Blumenthal, MD, vice president of Clinical Development Oncology at Merck in Silver Spring, Maryland. Drs Camidge and Blumenthal discussed Dr Blumenthal's experience serving on both sides of the oncology regulatory divide. Though initially leaning toward humanities during his education, he pursued a career in medicine. During medical school, he shifted his focus from neuroscience to oncology due to the field's high unmet need, fascinating drug development pathways, and the intensity of patient interaction. He chose to complete his hematology and oncology fellowship at the National Cancer Institute to immerse himself in translational oncology and drug development. Before joining industry, Dr Blumenthal also spent several years working for the FDA. He started there as a medical officer, focusing on all facets of drug development, from ethics and manufacturing to trial design and biostatistics. He emphasized that success at the FDA involves both approving effective agents and identifying drugs that do not work, maintaining transparency through venues like the public Oncologic Drug Advisory Committee meetings. He used FDA data to conduct independent meta-research, such as analyzing the correlation between response rates and overall survival in lung cancer. His proudest achievement at the FDA was helping to establish the Oncology Center of Excellence, which unified drug development reviews across different centers within the agency. Dr Blumenthal left the FDA in early 2020, seeking to gain direct experience in developing new therapeutics. Joining Merck, he first worked in regulatory affairs, navigating international regulations in addition to US filing procedures, which are typically prioritized in oncology. He later transitioned into clinical development, and currently focuses on new assets as Merck evolves its pipeline beyond pembrolizumab (Keytruda). Dr Blumenthal concluded that he is excited by the future of oncology, anticipating radical changes driven by new modalities and advanced biomarkers like artificial intelligence–driven digital pathology.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Mark Socinski, MD, a medical oncologist and the executive medical director of the AdventHealth Cancer Institute in Orlando, Florida. Drs Camidge and Socinski discussed the highlights of Dr Socinski's career trajectory, as well as the personal influences that helped him arrive where he is today. Socinski describes himself as a clinician and clinical investigator with 35 years of focus on lung cancer. His role as executive director of the AdventHealth Cancer Institute involves maintaining an active clinic 1 day a week and dedicating the rest of his time to administrative duties, including recruitment and building infrastructure at the institution. In the interview, Dr Socinski explained that he was influenced to enter a career in medicine because of role of the family practitioner he knew growing up. He went on to receive undergraduate and medical degrees from the University of Vermont in Burlington. After training at Dana-Farber Cancer Institute in Boston, Massachusetts, he began his career in private general oncology practice in Vermont before seeking a more academic, subspecialty environment. He joined the University of North Carolina to concentrate on lung cancer, where he pioneered dose-escalation trials using conformal radiotherapy. Dr Socinski then described his move to the University of Pittsburgh Medical Center in Pennsylvania. There, he became the chair of the lung pathway, which limits treatment options to a single, expert-agreed standard of care based on efficacy, toxicity, and cost, thus reducing treatment heterogeneity and controlling costs. Thereafter, Dr Socinski moved to AdventHealth, attracted by the institution's goal to achieve National Cancer Institute designation and build a major cancer program. Dr Socinski shared that he finds it gratifying to care for patients and lead the development of the institute.

Karns still sucks! D-Ross is on fire! And the Poofs are in shambles. Tiny Tony also makes an appearance again!!

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Ken Culver, MD, the director of Research and Clinical Affairs at ALK Positive Inc.  Drs Camidge and Culver discussed the highlights of Dr Culver's career, which has been shaped by clinical practice, research, industry leadership, and patient advocacy. They noted elements of ALK Positive that set it apart from other patient advocacy groups, including its being entirely created, funded, and led by patients with stage IV lung cancer and their caregivers. Culver explained how he collaborates with patients to expand treatment opportunities, meets with companies and universities worldwide, and helps stakeholders recognize both the unmet needs and financial incentives for developing therapies for ALK-positive lung cancer. Culver detailed his path to the oncology field, which began with an intention to practice as a community pediatrician in Iowa. This led him to pursue residency training in California, where he gained diverse clinical experience, particularly in HIV/AIDS at the height of the epidemic. His early research explored HIV transmission in children born to drug-using mothers, highlighting the immunosuppressive effect of drug abuse even in the absence of HIV. During his fellowship, he contributed to pioneering work in gene therapy. He also participated in research that laid the groundwork for tumor-directed therapies, which later influenced large-scale clinical trials. Eventually, Culver explained that transitioned to industry. At Novartis, he contributed to the development of important drugs and witnessed the transformative launch of imatinib (Gleevec), one of the first targeted cancer therapies. Alongside his professional work, Culver established the Foundation for Peace, a nonprofit providing medical and community support in the Dominican Republic, Haiti, and Kenya. This initiative, which began with a mission trip in 1989, has grown to involve hundreds of volunteers annually, offering both medical care and broader community services. In his current role with ALK Positive, Culver noted that he has leveraged patient-led advocacy to influence industry priorities, resulting in several new clinical trials for ALK-positive patients. His work emphasizes balancing discovery research with near-term clinical opportunities to directly benefit patients with cancer today. He also shared how he prioritizes tools to empower patients, such as clinical trial finders, and stressed the importance of having contingency plans before disease progression. Overall, this conversation highlights a career that reflects a consistent commitment to science, patient care, and global service, guided by both professional and humanitarian values.

En los años 70s en Bélmez de la Moraleda, una pequeña localidad de España, sucedió un acontecimiento que rápidamente llamó la atención de la prensa y los medios de comunicación locales.Se trataba de la casa de María Gómez, en la que y según ella misma lo contó "Mientras freía pimientos, pudo percatarse que en la loza de su casa, se había aparecido un rostro".Sin embargo la cosa no terminó ahí, posteriormente comenzaron a formarse mas rostros los cuales según algunos testimonios, incluso cobraron vida y cambiaron de forma.¿Se trata esto de un caso genuino de algo paranormal e inexplicable? ¿O estamos ante toda una comunidad solapando una estafa que les generó mucho dinero?¡No te lo pierdas y no olvides regalarnos tu like, suscribirte y comentar, eso ayuda muchísimo!
Si te gusta este podcast y deseas apoyarnos a mejorar nuestro equipo o invitarnos unos tacos puedes apoyarnos en

Camidge and Lee discussed Lee's professional journey and personal insights gained from years of working at the intersection of clinical research and patient care. 

Dross is undesirable material or junk that floats to the top when you are melting metal. The psalmist says that God discards all the wicked of the earth as dross, and that is why he loves God's testimonies. In this episode we consider what he means by that.Music Credit: Johann Sebastian Bach, Trio from Brandenburg Concerto, No. 1, Movement 4

This was a splendid crossword by Ben Zimmer. There were no rebuses, but the ingenious theme was a surprise and a delight. We give it a 5 squares on the JAMCR scale, and for the reasons why, have a listen to today's episode.A logistical note: we are going to be taking Friday and Saturday off, due to anticipated connectivity issues. But we will, of course, be doing the crossword, and will be back to talk about our cruciverbial exploits on Sunday.Show note imagery: The Minceta Tower (Dubrovnik) in CROATIA, the real home of the Game of ThronesWe love feedback! Send us a text...Contact Info:We love listener mail! Drop us a line, crosswordpodcast@icloud.com.Also, we're on FaceBook, so feel free to drop by there and strike up a conversation!

Drs Camidge and Blue discussed Dr Blue's journey into practicing medicine that led him to his current specialty: the management of malignant hematologic conditions.

Akram's enthusiasm for helping with the fete begins to backfire. Azra has little sympathy for his pressed schedule, and when he asks her to cover a meeting for him while he handles a plumbing emergency, she's unimpressed. Grudgingly she capitulates and attends the meeting, and despite her insistence she's there merely as a scribe, Lynda ropes her into contributing suggestions for a big idea. When Azra floats the idea of a traditional fete, Lynda seizes on it. Akram arrives just in time to be handed a growing list of tasks—including gauging public opinion and securing sponsorship. Tracy's astounded to hear Neil's invited Martyn Gibson to her birthday party, declaring it would be a disaster. Jazzer assures her Martyn declined, but reluctantly admits he himself left the door open in case Martyn found himself free. Tracy now doesn't know where things stand. She'll have to tidy the house, and they'll need to spill into the garden for more room. When Jazzer protests the garden's a tip, Tracy instructs him to do some weeding. She's initially impressed with his idea for live music, until she realises he means Dross. For Tracy this is a step too far. Kenton considers security options at the Bull. When his first choice of staffing is unavailable, Mick volunteers his services. He can start tonight. However his over-zealous approach almost scares Jazzer away, and Kenton suggests being unobtrusive and mingling with customers might be more effective than frisking them. Mick just needs to watch and listen.

While Keri and Matthew may be disappointed at the break up of Dross (again), they didn't let that stop them plugging in and turning themselves up to eleven this week.A huge thank you and welcome to new Patrons: David, Imogen, Julie and a mystery supporter, Massive props to John for his upgrade too.As always, a wider thank you to ALL of you who make this pod happen. BISOUS!Join us as we attend a Henry Ted Talk, we check out the county's latest influencer and we watch The Bull and The Buck battle it out for South Borsetshire's Best Pub.On our list of customer complaints:Belle End : Martyn's cocktail party turns sour.Keeping it Squeal : Amber enjoys her hay day.The Customer is Always Wrong : Eddie's form needs a good filling-in.Produced by Matthew WeirBecome a beautiful patron of The Cider Shed and receive early ad-free episodes and our exclusive Patreon-only midweek specials. It really REALLY helps us out.https://www.patreon.com/thecidershedTo help us out with a lovely worded 5 star review hit the link below. Then scroll down to ‘Ratings and Reviews' and a little further below that is ‘Write a Review' (this is so much nicer than just tapping the stars

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Catharine Young, PhD, who is currently a senior fellow at the Harvard T. H. Chan School of Public Health. Young was formerly the assistant director of Cancer Moonshot Policy and International Engagement in the White House Office of Science and Technology Policy in Washington, DC. Camidge and Young, a South African–born scientist, discussed Young's journey from Johannesburg to Charlotte, North Carolina. Young shared that after undergrad, where she majored in biology, she joined a post-baccalaureate fellowship at the National Institute of Alcoholism and Alcohol Abuse, sparking her passion for research. This led her to pursue a PhD in biomedical sciences at the University of Missouri, focusing on the brain's role in regulating blood pressure. Catherine noted the challenges of changing labs mid-PhD and her eventual decision to step away from academia. During her postdoc, Young was inspired by her advisor's science policy fellowship, leading her to pursue a fellowship herself. She was matched with the US Department of Defense, working on chemical and biological threat reduction in former Soviet states and West Africa during the Ebola outbreak. Though she described the experience was eye-opening, she eventually shifted career paths, realizing that long-term government work wasn't the right fit for her career goals. From there, Young worked for the British Embassy in Washington, DC, bridging UK and US science priorities. She then joined the Biden Cancer Initiative, continuing the Cancer Moonshot's momentum through its ups and downs. Young reflected on how her variety of experiences led her to launch the Cancer Moonshot to new heights as she worked to advance cancer research and patient care through cancer-related policy and global engagement. Young concluded by highlighting her passion for continuing to expand medical treatment access worldwide.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Catharine Young, PhD, who is currently a senior fellow at the Harvard T. H. Chan School of Public Health. Young was formerly the assistant director of Cancer Moonshot Policy and International Engagement in the White House Office of Science and Technology Policy in Washington, DC. Camidge and Young, a South African–born scientist, discussed Young's journey from Johannesburg to Charlotte, North Carolina. Young shared that after undergrad, where she majored in biology, she joined a post-baccalaureate fellowship at the National Institute of Alcoholism and Alcohol Abuse, sparking her passion for research. This led her to pursue a PhD in biomedical sciences at the University of Missouri, focusing on the brain's role in regulating blood pressure. Catherine noted the challenges of changing labs mid-PhD and her eventual decision to step away from academia. During her postdoc, Young was inspired by her advisor's science policy fellowship, leading her to pursue a fellowship herself. She was matched with the US Department of Defense, working on chemical and biological threat reduction in former Soviet states and West Africa during the Ebola outbreak. Though she described the experience was eye-opening, she eventually shifted career paths, realizing that long-term government work wasn't the right fit for her career goals. From there, Young worked for the British Embassy in Washington, DC, bridging UK and US science priorities. She then joined the Biden Cancer Initiative, continuing the Cancer Moonshot's momentum through its ups and downs. Young reflected on how her variety of experiences led her to launch the Cancer Moonshot to new heights as she worked to advance cancer research and patient care through cancer-related policy and global engagement. Young concluded by highlighting her passion for continuing to expand medical treatment access worldwide.

Camidge and O'Riordan discussed how O'Riordan's breast surgery career intersected with her personal experience with breast cancer. She shared the stories behind her initial diagnosis, subsequent treatments, and disease recurrences. She also emphasized the importance of open communication with patients about aspects of cancer survivorship, such as emotional wellbeing and sexual health. O'Riordan also talked about her career transition from the surgery field to patient advocacy, as well as her future plans for writing, speaking, and offering support to the breast cancer community. 

Ed returns to the studio to discuss his Journalism in Northern Ireland, where he was on the ground reporting on the Ballymena riots. Oli joins him to create the platonic ideal of a podcast.Support PoliticsJOE's journalism: https://www.patreon.com/PoliticsJOE(0:00:00) Dross(0:10:01) PoliticsJOE Premium(0:22:40) Witches(0:26:18) Ballymena Hosted on Acast. See acast.com/privacy for more information.

For the last three seasons, the genre bending series Yellowjackets has mesmerized audiences. In this episode of Editors on Editing, Glenn Garland interviews four of the editors. Jeff Israel, whose credits include Tell Me Lies, Them, Apples Never Fall and Cruel Summer. Daniel Williams who has edited episodes for Sacred Lies, Them, Seal Team and One Piece. Genevieve Butler, who has edited Them and Tell Me Lies and Kevin D. Ross whose credits include Californication, Halt and Catch Fire and Stranger Things for which he was nominated twice for both the Eddie and the Primetime Emmy.Thanks again to ACE for partnering with us on this podcast, check out their website for more.And thank you to Sohonet for their support! Check out their site here: ⁠⁠https://www2.sohonet.com/editorialWant to see more interviews from Glenn? Check out "Editors on Editing" here.The Art of the Frame podcast is available on Apple Podcasts, Spotify, Google Podcasts, Anchor and many more platforms. If you like the podcast, make sure to subscribe so you don't miss future episodes and, please leave a review so more people can find our show!

Camidge and Machos discussed Machos' early career transition from pre-med to sales; her role in building strategic partnerships with key opinion leaders in oncology; and her involvement in the Miss New Hampshire and Miss America programs, which provided significant career-shaping opportunities. 

Drs Camidge and Lin discuss Dr Lin's work with brain metastases, her role in developing targeted therapies for breast cancer, the importance of systemic therapy for managing brain metastases, and the significance of mentoring the next generation of oncologist.

Acknowledge The Dross

In the 290th edition of Wiz Talk with Chase, Chase Coburn sits down to break down his Three Wizardy Notes and findings that he's seen when watching the Wizards over these past few weeks. And despite how ugly it sometimes gets, there are many reasons to smile, get excited and be passionate about the nation's capital basketball squad.Wiz Talk with Chase: podcasters.spotify.com/chase085 Cool Sports Network: podcasters.spotify.com/chase-coburn Chase's Sports News: chasessportsnews.com Cool Sports Newsletter: chasecoburn.substack.comInstagram: chases_sports_news X (Twitter): Chase Coburn (@coolsportskid) Profile @ The League Winners: theleaguewinners.com/author/chase/ Chase's Sports News YT: youtube.com/@csn504

Still your tongue, cat. And activate your ears, as this time we're receiving Japanese turd confirmation, roughing up Dross with kicks and pows, self-realizing limitations, sassing up “driveway,” getting ripped off on Black Rose Street, deploring a PMS joke, exposing beastwoman babes, talking on the world map, blowing the Vane reveal on PSP, stroking Nash's ego, stretching out a floor mat, burying the dragon tribe, conjuring memories of Phacia, and realizing Phacia has red eyes. “And I'm always been comfortable with my body.” 00:00:00 Video 00:01:54 Intro 00:04:14 Sega CD Sewage 00:06:44 Goodbye, Ramus 00:21:27 Meriba NPCs 00:25:11 Black Rose Street NPCs 00:29:42 Docks 00:31:50 Mel's Mansion 00:35:37 Fun Traveling 00:40:20 Spring of Transmission 00:46:48 Althena's Shrine 00:58:34 Phacia Room 01:12:06 Real Net 01:18:46 Outro Patreon: patreon.com/retroam Bluesky: @retrogradeamnesia.bsky.social YouTube: www.youtube.com/@RetrogradeAmnesia E-Mail: podcast@retrogradeamnesia.com Website: www.retrogradeamnesia.com  

It's a dead man's party. That's what podcasts are called on Lunar, where we're realizing no underclass exists in Meribia, understanding Mel only trusts beastmen with weapons, verifying interspecies erotica, debating ho ho ho vs bwa ha ha, fist fighting a Hero, slandering lawyers and accountants, cringing at crushing on Jessica, locking tighter than a tenement in South Central, leaving a dent in your skull, slipping on drool, becoming victimized, getting son'd by Mel, dealing with The Guild of Brett, pushing buttons to make bridges, slaying a dragon, and having no doubt that she is the one. Now you have a friend in the Dragon Diamond business. 00:00 Intro 03:02 Mel's Mansion 12:48 Hell Mel 18:35 Fighting Mel 21:54 Mel's Mansion II 33:22 Selling The Diamond 39:03 We've Been Had 44:08 Merbian Sewers 50:14 Water Dragon 54:41 Dross' Humiliation Ritual 59:49 Real Net 01:05:56 Outro  Patreon: patreon.com/retroam Bluesky: @retrogradeamnesia.bsky.social YouTube: www.youtube.com/@RetrogradeAmnesia E-Mail: podcast@retrogradeamnesia.com Website: www.retrogradeamnesia.com